Compare CRMD & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRMD | TRTX |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.9M | 659.4M |
| IPO Year | 2009 | N/A |
| Metric | CRMD | TRTX |
|---|---|---|
| Price | $7.87 | $8.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $14.83 | $9.83 |
| AVG Volume (30 Days) | ★ 1.2M | 687.8K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 11.55% |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | $8.78 |
| Revenue Next Year | N/A | $4.14 |
| P/E Ratio | $18.72 | ★ $14.82 |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $7.57 |
| 52 Week High | $14.96 | $9.85 |
| Indicator | CRMD | TRTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.72 | 55.74 |
| Support Level | $7.50 | $8.59 |
| Resistance Level | $9.02 | $8.73 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 13.57 | 67.00 |
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.